H. B. El-serag and K. L. Rudolph, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

, Gastroenterology, vol.132, pp.2557-2576, 2007.

H. B. El-serag, J. A. Marrero, L. Rudolph, and K. R. Reddy, Diagnosis and treatment of hepatocellular carcinoma, Gastroenterology, vol.134, pp.1752-1763, 2008.

A. P. Venook, C. Papandreou, J. Furuse, and L. L. De-guevara, The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective, Oncologist, vol.15, pp.5-13, 2010.

H. B. El-serag, Hepatocellular carcinoma, N Engl J Med, vol.365, pp.1118-1127, 2011.

P. Bodin and G. Burnstock, Purinergic signalling: ATP release, Neurochem Res, vol.26, pp.959-969, 2001.

P. Pellegatti, L. Raffaghello, G. Bianchi, F. Piccardi, V. Pistoia et al., Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase, PLoS One, vol.3, p.2599, 2008.

S. Falzoni, G. Donvito, D. Virgilio, and F. , Detecting adenosine triphosphate in the pericellular space, Interface Focus, vol.3, 2013.

V. Ralevic and G. Burnstock, Receptors for purines and pyrimidines, Pharmacol Rev, vol.50, pp.413-492, 1998.

R. A. North, Molecular physiology of P2X receptors, Physiol Rev, vol.82, pp.1013-1067, 2002.

B. S. Khakh and R. A. North, P2X receptors as cell-surface ATP sensors in health and disease, Nature, vol.442, pp.527-532, 2006.

L. H. Jiang, P2X receptor-mediated ATP purinergic signaling in health and disease, Cell Health Cytoskelet, vol.4, pp.83-101, 2010.

L. E. Browne, L. H. Jiang, and R. A. North, New structure enlivens interest in P2X receptors, Trends Pharmacol Sci, vol.31, pp.229-237, 2010.

R. A. North and A. Surprenant, Pharmacology of cloned P2X receptors, Annu Rev Pharmacol Toxicol, vol.40, pp.563-580, 2000.

I. Von-kügelgen and T. K. Harden, Molecular pharmacology, physiology, and structure of the P2Y receptors, Adv Pharmacol, vol.61, pp.373-415, 2011.

D. Virgilio and F. Purines, cancer. Cancer Res, vol.72, pp.5441-5447, 2012.

E. Adinolfi, F. Amoroso, and A. L. Giuliani, P2X7 Receptor Function in Bone-Related Cancer, J Osteoporos, p.637863, 2012.

E. Adinolfi, M. Capece, F. Amoroso, D. Marchi, E. Franceschini et al., Emerging roles of P2X receptors in cancer, Curr Med Chem, vol.22, pp.878-890, 2015.

S. Roger, B. Jelassi, I. Couillin, P. Pelegrin, P. Besson et al., Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives, Biochim Biophys Acta, vol.1848, pp.2584-2602, 2015.

J. X. Jiang, M. A. Riquelme, and J. Z. Zhou, ATP, a double-edged sword in cancer, Oncoscience, vol.2, pp.673-674, 2015.

G. P. Gupta and J. Massagué, Cancer metastasis: building a framework, Cell, vol.127, pp.679-695, 2006.

E. Adinolfi, L. Melchiorri, S. Falzoni, P. Chiozzi, A. Morelli et al., P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia, Blood, vol.99, pp.706-708, 2002.

E. Adinolfi, M. Cirillo, R. Woltersdorf, S. Falzoni, P. Chiozzi et al., Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor, FASEB J, vol.24, pp.3393-3404, 2010.

E. Adinolfi, L. Raffaghello, A. L. Giuliani, L. Cavazzini, M. Capece et al., Expression of P2X7 receptor increases in vivo tumor growth, Cancer Res, vol.72, pp.2957-2969, 2012.

B. Jelassi, A. Chantôme, F. Alcaraz-pérez, A. Baroja-mazo, M. L. Cayuela et al., P2X7 receptor activation enhances SK3 channels-and cysteine cathepsin-dependent cancer cells invasiveness, Oncogene, vol.30, pp.2108-2122, 2011.

B. Jelassi, M. Anchelin, J. Chamouton, M. L. Cayuela, L. Clarysse et al., Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors, Carcinogenesis, vol.34, pp.1487-1496, 2013.

A. L. Giuliani, D. Colognesi, T. Ricco, C. Roncato, M. Capece et al., Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma, PLoS One, vol.9, p.107224, 2014.

Y. Qiu, W. H. Li, H. Q. Zhang, Y. Liu, X. X. Tian et al., P2X7 mediates ATP-driven invasiveness in prostate cancer cells, PLoS One, vol.9, p.114371, 2014.

J. Xia, X. Yu, L. Tang, G. Li, and T. He, P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway, Oncol Rep, vol.34, pp.103-110, 2015.

J. Z. Zhou, M. A. Riquelme, X. Gao, L. G. Ellies, L. Z. Sun et al., Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis, Oncogene, vol.34, pp.1831-1842, 2015.

E. Adinolfi, M. Capece, A. Franceschini, S. Falzoni, A. L. Giuliani et al., Accelerated tumor progression in mice lacking the ATP receptor P2X7, Cancer Res, vol.75, pp.635-644, 2015.

F. Amoroso, M. Capece, A. Rotondo, D. Cangelosi, M. Ferracin et al., The P2X7 receptor is a key modulator of the PI3K/ GSK3?/VEGF signaling network: evidence in experimental neuroblastoma, Oncogene, vol.34, pp.5240-5251, 2015.

A. Giannuzzo, S. F. Pedersen, and I. Novak, The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells, Mol Cancer, vol.14, p.203, 2015.

W. H. Li, Y. Qiu, H. Q. Zhang, Y. Liu, J. F. You et al., P2Y 2 receptor promotes cell invasion and metastasis in prostate cancer cells, Br J Cancer, vol.109, pp.1666-1675, 2013.

D. Schumacher, B. Strilic, K. K. Sivaraj, N. Wettschureck, and S. Offermanns, Platelet-derived nucleotides promote tumorcell transendothelial migration and metastasis via P2Y 2 receptor, Cancer Cell, vol.24, pp.130-137, 2013.

H. Jin, S. Y. Eun, J. S. Lee, S. W. Park, J. H. Lee et al., P2Y 2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells, Breast Cancer Res, vol.16, p.77, 2014.

S. Chadet, B. Jelassi, R. Wannous, D. Angoulvant, S. Chevalier et al., The activation of P2Y 2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway, Carcinogenesis, vol.35, pp.1238-1247, 2014.

R. Xie, J. Xu, G. Wen, H. Jin, X. Liu et al., The P2Y 2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP, J Biol Chem, vol.289, pp.19137-19149, 2014.

C. Schöfl, M. Ponczek, T. Mader, M. Waring, H. Benecke et al., Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes, Am J Physiol, vol.276, pp.164-172, 1999.

D. S. Emmett, A. Feranchak, G. Kilic, L. Puljak, B. Miller et al., oncotarget Characterization of ionotrophic purinergic receptors in hepatocytes, Hepatology, vol.47, pp.698-705, 2008.

H. Zimmermann, Extracellular metabolism of ATP and other nucleotides, Naunyn Schmiedebergs Arch Pharmacol, vol.362, pp.299-309, 2000.

P. Friedl and S. Alexander, Cancer invasion and the microenvironment: plasticity and reciprocity, Cell, vol.147, pp.992-1009, 2011.

K. Wolf, Y. I. Wu, Y. Liu, J. Geiger, E. Tam et al., Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion, Nat Cell Biol, vol.9, pp.893-904, 2007.

K. Wolf and P. Friedl, Extracellular matrix determinants of proteolytic and non-proteolytic cell migration, Trends Cell Biol, vol.21, pp.736-780, 2011.

E. Bon, V. Driffort, F. Gradek, C. Martinez-caceres, M. Anchelin et al., SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer, Nat Commun, vol.7, p.13648, 2016.

H. Peng, Y. Hao, F. Mousawi, S. Roger, J. Li et al., Purinergic and storeoperated Ca 2+ signaling mechanisms in mesenchymal stem cells and their roles in ATP-Induced stimulation of cell migration, Stem Cells, vol.34, pp.2102-2014, 2016.